Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/22/2025
-
MarketBeat
5/24/2025
-
Zero Hedge
5/24/2025
-
MarketBeat
5/24/2025
-
TheStreet.com
5/24/2025
-
GuruFocus
5/24/2025
-
GuruFocus
5/23/2025
-
Insider Monkey
5/23/2025
-
GuruFocus
5/23/2025
-
GuruFocus
5/23/2025
-
TipRanks Financial Blog
5/23/2025
-
The Fly
5/23/2025
-
Accesswire
5/23/2025
-
Fortune
5/23/2025
-
Ticker Report
5/23/2025
-
MarketBeat
5/22/2025
-
Benzinga
5/22/2025
-
Zero Hedge
5/22/2025
-
Zero Hedge
5/22/2025
-
Zacks Investment Research
5/22/2025
-
Stock Options Channel
5/22/2025
-
Zacks Investment Research
5/22/2025
-
GuruFocus
5/22/2025
-
GuruFocus
5/22/2025
-
MarketBeat
3/15/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 714 6500
Address
325 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID...
more